Lyell Immunopharma, Inc. (LYEL)

19.12 -1.65 (-7.94%) USD  |  NASDAQ  |  Mar 20, 16:00
19.07 -0.05 (-0.26%) After-Hours: 20:00
More

Lyell Immunopharma EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for LYEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Nektar Therapeutics Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
SELLAS Life Sciences Group, Inc. Upgrade
Fortress Biotech, Inc. Upgrade